A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
Public ClinicalTrials.gov record NCT03305016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
fliGHt: A Multicenter, Phase 3, Open-Label, 26-Week Trial Investigating the Safety, Tolerability and Efficacy of TransCon hGH Administered Once Weekly in Children With GHD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A 26 week trial of TransCon hGH, a long-acting growth hormone product, administered once-a-week. Approximately 150 children (males and females) with growth hormone deficiency (GHD) will be included. All study participants will receive TransCon hGH. This is a global trial that will be conducted in, but not limited to, the United States, Canada, Australia, and New Zealand.
Study identification
- NCT ID
- NCT03305016
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 146 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Months to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 13, 2017 (Actual)
- Primary completion
- Mar 19, 2019 (Actual)
- Completion
- Mar 19, 2019 (Actual)
- Last update posted
- Jul 7, 2026
2017 – 2019
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35233 | — |
| Neufeld Medical Group Inc. | Los Angeles | California | 90048 | — |
| Center of Excellence in Diabetes and Endocrinology | Sacramento | California | 95821 | — |
| Rocky Mountain Pediatric Endocrinology | Centennial | Colorado | 80112 | — |
| Nemours Children's Health System | Jacksonville | Florida | 32207 | — |
| Orlando Health Inc. | Orlando | Florida | 32806 | — |
| Tallahassee Memorial Hospital | Tallahassee | Florida | 32308 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Children's Minnesota | Saint Paul | Minnesota | 55102 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| NYU Winthrop Hospital | Mineola | New York | 11501 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Children's Diabetes and Endocrine Center | Portland | Oregon | 97227 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Children's Medical Center | Dallas | Texas | 75235 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| University of Virginia Children's Hospital | Charlottesville | Virginia | 22903 | — |
| Children's Hospital of The King's Daughters | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03305016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2026 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03305016 live on ClinicalTrials.gov.